Literature DB >> 19304866

MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study.

V Raj1, H C Liang, N D Woodward, A L Bauernfeind, J Lee, M S Dietrich, S Park, R L Cowan.   

Abstract

3,4-methylenedioxymethamphetamine (MDMA) users have impaired verbal memory, and voxel-based morphometry has shown decreased grey matter in Brodmann area (BA) 18, 21 and 45. Because these regions play a role in verbal memory, we hypothesized that MDMA users would show altered brain activation in these areas during performance of a functional magnetic resonance imaging (fMRI) task that probed semantic verbal memory. Polysubstance users enriched for MDMA exposure participated in a semantic memory encoding and recognition fMRI task that activated left BA 9, 18, 21/22 and 45. Primary outcomes were percent blood oxygen level-dependent signal change in left BA 9, 18, 21/22 and 45, accuracy and response time. During semantic recognition, lifetime MDMA use was associated with decreased activation in left BA 9, 18 and 21/22 but not 45. This was partly influenced by contributions from cannabis and cocaine use. MDMA exposure was not associated with accuracy or response time during the semantic recognition task. During semantic recognition, MDMA exposure was associated with reduced regional brain activation in regions mediating verbal memory. These findings partially overlap with previous structural evidence for reduced grey matter in MDMA users and may, in part, explain the consistent verbal memory impairments observed in other studies of MDMA users.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304866      PMCID: PMC3198867          DOI: 10.1177/0269881109103203

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  91 in total

1.  Applying Bradford Hill's criteria for causation to neuropsychiatry: challenges and opportunities.

Authors:  R van Reekum; D L Streiner; D K Conn
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

2.  Neuropsychological performance in long-term cannabis users.

Authors:  H G Pope; A J Gruber; J I Hudson; M A Huestis; D Yurgelun-Todd
Journal:  Arch Gen Psychiatry       Date:  2001-10

Review 3.  Prefrontal cortex and working memory processes.

Authors:  S Funahashi
Journal:  Neuroscience       Date:  2005-12-01       Impact factor: 3.590

Review 4.  MDMA use and neurocognition: a meta-analytic review.

Authors:  Ari D Kalechstein; Richard De La Garza; James J Mahoney; William E Fantegrossi; Thomas F Newton
Journal:  Psychopharmacology (Berl)       Date:  2006-11-03       Impact factor: 4.530

Review 5.  MDMA: historical perspectives.

Authors:  J W Gibb; M Johnson; D Stone; G R Hanson
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 6.  Chemistry of the mind: neurochemical modulation of prefrontal cortical function.

Authors:  Trevor W Robbins
Journal:  J Comp Neurol       Date:  2005-12-05       Impact factor: 3.215

7.  Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging.

Authors:  L Reneman; C B Majoie; J B Habraken; G J den Heeten
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

Review 8.  Serotonin and human cognitive performance.

Authors:  J A J Schmitt; M Wingen; J G Ramaekers; E A T Evers; W J Riedel
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

9.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

10.  Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users.

Authors:  Konstantine K Zakzanis; Donald A Young; Nasim F Radkhoshnoud
Journal:  Appl Neuropsychol       Date:  2002
View more
  7 in total

1.  fNIRS suggests increased effort during executive access in ecstasy polydrug users.

Authors:  C A Roberts; C Montgomery
Journal:  Psychopharmacology (Berl)       Date:  2014-11-14       Impact factor: 4.530

2.  Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Authors:  Christina R Di Iorio; Tristan J Watkins; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Baxter Rogers; Mohammed S Ansari; Ronald M Baldwin; Rui Li; Robert M Kessler; Ronald M Salomon; Margaret Benningfield; Ronald L Cowan
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

3.  Human Ecstasy use is associated with increased cortical excitability: an fMRI study.

Authors:  Amy L Bauernfeind; Mary S Dietrich; Jennifer U Blackford; Evonne J Charboneau; James G Lillevig; Christopher J Cannistraci; Neil D Woodward; Aize Cao; Tristan Watkins; Christina R Di Iorio; Carissa Cascio; Ronald M Salomon; Ronald L Cowan
Journal:  Neuropsychopharmacology       Date:  2011-02-16       Impact factor: 7.853

4.  Resting state functional connectivity in alcohol users and co-users of other substances.

Authors:  Vanessa Morris; Sabrina K Syan; James MacKillop; Michael Amlung
Journal:  Psychiatry Res Neuroimaging       Date:  2022-02-17       Impact factor: 2.493

5.  Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Authors:  Tristan J Watkins; Vidya Raj; Junghee Lee; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Ronald M Salomon; Sohee Park; Margaret M Benningfield; Christina R Di Iorio; Ronald L Cowan
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

6.  Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.

Authors:  Una D McCann; Michael J Wilson; Francis P Sgambati; George A Ricaurte
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

7.  MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase.

Authors:  John H Anneken; Jacobi I Cunningham; Stuart A Collins; Bryan K Yamamoto; Gary A Gudelsky
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.